Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.
Saved in:
| Title: | Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer. |
|---|---|
| Authors: | Wangpaichitr M; Miami VA Healthcare System, Research Service, Miami, FL, USA.; Department of Surgery, Cardiothoracic Surgery, University of Miami, Miami, FL, USA., Wu C; Miami VA Healthcare System, Research Service, Miami, FL, USA., Li YY; Department of Medicine, Hematology/Oncology, University of Miami, Miami, FL, USA., Nguyen DJM; Department of Biology, University of Miami, Miami, FL, USA., Kandemir H; School of Medicine, Koc University, Istanbul, Turkey., Shah S; Department of Biology, University of Miami, Miami, FL, USA., Chen S; Department of Neurosurgery, Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan., Feun LG; Department of Medicine, Hematology/Oncology, University of Miami, Miami, FL, USA., Prince JS; Department of Biology, University of Miami, Miami, FL, USA., Kuo MT; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Savaraj N; Miami VA Healthcare System, Research Service, Miami, FL, USA.; Department of Medicine, Hematology/Oncology, University of Miami, Miami, FL, USA. |
| Source: | Oncotarget [Oncotarget] 2017 Jul 25; Vol. 8 (30), pp. 49275-49292. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
